WOODBURY, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its third quarter of 2025. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments.
• | Who: Joseph M. Harary, President & CEO | |
• | Date/Time: Thursday, November 6, 2025, 4:30 PM ET | |
• | Dial-in Information:1-888-334-5785 | |
• | Conference Link: https://join.broaddata.com/?id=research-frontiers | |
• | Replay: Available on Friday, November 7, 2025 for 90 days at https://smartglass-ir.com/ | |
Key Comments:
1. | Newly-Introduced Retrofit System for SPD-SmartGlass in the Architectural Market. |
2. | Automotive Market Growth and Expansion. |
3. | Industry Recognition and Leadership. |
4. | Technology Outlook. |
5. | Operational Results and Financial Stability. |
“SPD-SmartGlass is gaining traction worldwide. Whether it’s the retrofit glass system unveiled this week in Orlando or the expanding list of automotive, aircraft and architectural programs, our licensees are proving that SPD-SmartGlass technology delivers performance, reliability, and scalability. We’ve built the foundation, and now we’re seeing that effort translate into market momentum and global recognition.” said Joseph M. Harary, President and CEO of Research Frontiers.
For more details, please see the Company’s Quarterly Report on Form 10-Q which was filed today with the SEC, the contents of which are incorporated by reference herein.
About Research Frontiers
Research Frontiers (Nasdaq: REFR) is a publicly traded technology company and the developer of patented SPD-Smart light-control film technology which allows users to instantly, precisely and uniformly control the shading of glass or plastic products, either manually or automatically. Research Frontiers has licensed its smart glass technology to numerous companies that include well known chemical, material science and glass companies. Products using Research Frontiers’ smart glass technology are being used in tens of thousands of cars, aircraft, yachts, trains, homes, offices, museums and other buildings. For more information, please visit our website at www.SmartGlass.com, and on Facebook, Twitter, LinkedIn and YouTube.
Note: From time to time Research Frontiers may issue forward-looking statements which involve risks and uncertainties. This press release contains forward-looking statements. Actual results, especially those reliant on activities by third parties, could differ and are not guaranteed. Any forward-looking statements should be considered accordingly. “SPD-Smart” and “SPD-SmartGlass” are trademarks of Research Frontiers Inc.
CONTACT:
Joseph M. Harary
President and CEO
Research Frontiers Inc.
+1-516-364-1902
Info@SmartGlass.com
RESEARCH FRONTIERS INCORPORATED
Condensed Consolidated Balance Sheets
September 30, 2025 | December 31, 2024 | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 1,130,390 | $ | 1,994,186 | ||||
Royalties receivable, net of reserves of $1,354,850 in 2025 and $1,253,450 in 2024, respectively | 371,878 | 658,213 | ||||||
Prepaid expenses and other current assets | 112,604 | 93,490 | ||||||
Total current assets | 1,614,872 | 2,745,889 | ||||||
Fixed assets, net | 6,355 | 15,052 | ||||||
Operating lease ROU assets | 1,092,033 | 1,222,640 | ||||||
Deposits and other assets | 56,066 | 56,066 | ||||||
Total assets | $ | 2,769,326 | $ | 4,039,647 | ||||
Liabilities and Shareholders’ Equity | ||||||||
Current liabilities: | ||||||||
Current portion of operating lease liability | $ | 141,894 | $ | 129,875 | ||||
Accounts payable | 29,137 | 85,825 | ||||||
Accrued expenses | 35,721 | 53,327 | ||||||
Deferred revenue | 5,336 | - | ||||||
Total current liabilities | 212,088 | 269,027 | ||||||
Operating lease liability, net of current portion | 1,057,720 | 1,166,285 | ||||||
Total liabilities | 1,269,808 | 1,435,312 | ||||||
Shareholders’ equity: | ||||||||
Common stock, par value $0.0001 per share; authorized 100,000,000 shares, issued and outstanding 33,648,221 in 2025 and 2024, respectively | 3,365 | 3,365 | ||||||
Additional paid-in capital | 128,352,397 | 128,177,193 | ||||||
Accumulated deficit | (126,856,244 | ) | (125,576,223 | ) | ||||
Total shareholders’ equity | 1,499,518 | 2,604,335 | ||||||
Total liabilities and shareholders’ equity | $ | 2,769,326 | $ | 4,039,647 | ||||
RESEARCH FRONTIERS INCORPORATED
Condensed Consolidated Statements of Operations
(Unaudited)
Nine months ended September 30, | Three months ended September 30, | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
Fee income | $ | 1,049,125 | $ | 1,157,380 | $ | 359,444 | $ | 354,408 | ||||||||
Operating expenses | 1,934,041 | 1,565,152 | 521,642 | 454,866 | ||||||||||||
Research and development | 473,709 | 409,817 | 141,746 | 131,246 | ||||||||||||
Total expenses | 2,407,750 | 1,974,969 | 663,388 | 586,112 | ||||||||||||
Operating loss | (1,358,625 | ) | (817,589 | ) | (303,944 | ) | (231,704 | ) | ||||||||
Net interest income | 31,247 | 78,995 | 5,436 | 29,736 | ||||||||||||
Other income | 47,357 | 35,152 | - | 35,152 | ||||||||||||
Net loss | $ | (1,280,021 | ) | $ | (703,442 | ) | $ | (298,508 | ) | $ | (166,816 | ) | ||||
Basic and diluted net loss per common share | $ | (0.04 | ) | $ | (0.02 | ) | $ | (0.01 | ) | $ | (0.00 | ) | ||||
Weighted average number of common shares outstanding | 33,648,221 | 33,515,327 | 33,648,221 | 33,517,787 | ||||||||||||
RESEARCH FRONTIERS INCORPORATED
Condensed Consolidated Statements of Shareholders’ Equity
(Unaudited)
For the nine months ended September 30, 2025 and 2024
Common Stock | Additional | Accumulated | ||||||||||||||||||
Shares | Amount | Paid-in Capital | Deficit | Total | ||||||||||||||||
Balance, January 1, 2024 | 33,509,287 | $ | 3,351 | $ | 127,779,221 | $ | (124,264,841 | ) | $ | 3,517,731 | ||||||||||
Exercise of options | 8,500 | 1 | 8,669 | - | 8,670 | |||||||||||||||
Net loss | - | - | - | (703,442 | ) | (703,442 | ) | |||||||||||||
Balance, September 30, 2024 | 33,517,787 | $ | 3,352 | $ | 127,787,890 | $ | (124,968,283 | ) | $ | 2,822,959 | ||||||||||
Balance, January 1, 2025 | 33,648,221 | $ | 3,365 | $ | 128,177,193 | $ | (125,576,223 | ) | $ | 2,604,335 | ||||||||||
Share-based compensation | - | - | 175,204 | - | 175,204 | |||||||||||||||
Net loss | - | - | - | (1,280,021 | ) | (1,280,021 | ) | |||||||||||||
Balance, September 30, 2025 | 33,648,221 | $ | 3,365 | $ | 128,352,397 | $ | (126,856,244 | ) | $ | 1,499,518 | ||||||||||
For the three months ended September 30, 2025 and 2024
Common Stock | Additional | Accumulated | ||||||||||||||||||
Shares | Amount | Paid-in Capital | Deficit | Total | ||||||||||||||||
Balance, June 30, 2024 | 33,517,787 | $ | 3,352 | $ | 127,787,890 | $ | (124,801,467 | ) | $ | 2,989,775 | ||||||||||
Net loss | - | - | - | (166,816 | ) | (166,816 | ) | |||||||||||||
Balance, September 30, 2024 | 33,517,787 | $ | 3,352 | $ | 127,787,890 | $ | (124,968,283 | ) | $ | 2,822,959 | ||||||||||
Balance, June 30, 2025 | 33,648,221 | $ | 3,365 | $ | 128,352,397 | $ | (126,557,736 | ) | $ | 1,798,026 | ||||||||||
Net loss | - | - | - | (298,508 | ) | (298,508 | ) | |||||||||||||
Balance, September 30, 2025 | 33,648,221 | $ | 3,365 | $ | 128,352,397 | $ | (126,856,244 | ) | $ | 1,499,518 | ||||||||||
RESEARCH FRONTIERS INCORPORATED
Condensed Consolidated Statements of Cash Flows
(Unaudited)
Nine months ended September 30, | ||||||||
2025 | 2024 | |||||||
Cash flows from operating activities: | ||||||||
Net loss | $ | (1,280,021 | ) | $ | (703,442 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | 9,279 | 19,582 | ||||||
Share-based compensation | 175,204 | - | ||||||
Credit loss expense | 124,253 | 25,001 | ||||||
ROU asset amortization | 130,607 | 107,229 | ||||||
Change in assets and liabilities: | ||||||||
Royalty receivables | 162,082 | (69,605 | ) | |||||
Prepaid expenses and other assets | (19,114 | ) | (57,943 | ) | ||||
Accounts payable and accrued expenses | (74,294 | ) | 1,033 | |||||
Deferred revenue | 5,336 | - | ||||||
Operating lease liability | (96,546 | ) | (157,754 | ) | ||||
Net cash used in operating activities | (863,214 | ) | (835,899 | ) | ||||
Cash flows from investing activities: | ||||||||
Purchases of fixed assets | (582 | ) | (742 | ) | ||||
Net cash used in investing activities | (582 | ) | (742 | ) | ||||
Cash flows from financing activities: | ||||||||
Net proceeds from exercise of options | - | 8,670 | ||||||
Net cash provided by financing activities | - | 8,670 | ||||||
Net decrease in cash and cash equivalents | (863,796 | ) | (827,971 | ) | ||||
Cash and cash equivalents at beginning of year | 1,994,186 | 2,475,958 | ||||||
Cash and cash equivalents at end of period | $ | 1,130,390 | $ | 1,647,987 | ||||